Muzaffar Qazilbash
@transplant_doc
Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own
ID: 162587280
http://faculty.mdanderson.org/Muzaffar_Qazilbash/Default.asp 04-07-2010 03:26:14
19,19K Tweet
7,7K Takipçi
259 Takip Edilen
SOC Ide-cel for RRMM: A CIBMTR Analysis. N=821, median prior LOT: 7, 15% with prior anti-BCMA Rx. ORR/CR: 73/25%, median PFS: 8.8 months. NRM: 6%, SPM: 4%. #mmsm #bmtsm Surbhi Sidana, MD Nausheen Ahmed MD sganguly CIBMTR ashpublications.org/blood/article/…